Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × NETWORK × Peritoneal Neoplasms × Clear all

Phase

Phase 3 1 Phase 2/3 1

Status

Sponsor Class

OTHER 2 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Lymphoma 4 Colorectal Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Xerostomia 1 Warts 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Tongue Neoplasms 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Teratoma 1 Stomach Neoplasms 1 Sezary Syndrome 1 Seminoma 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Salivary Gland Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Previously Treated Non-Small Cell Lung Cancer 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Pain 1

Interventions

Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Magnetic Resonance Spectroscopy 1 Laparoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07001748 2026-03-23

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡